GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NDT Pharmaceuticals Inc (OTCPK:NDTP) » Definitions » EPS (Diluted)

NDT Pharmaceuticals (NDT Pharmaceuticals) EPS (Diluted) : $-30.43 (TTM As of Jun. 2008)


View and export this data going back to 2006. Start your Free Trial

What is NDT Pharmaceuticals EPS (Diluted)?

NDT Pharmaceuticals's Earnings per Share (Diluted) for the three months ended in Jun. 2008 was $-4.43. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2008 was $-30.43.

NDT Pharmaceuticals's EPS (Basic) for the three months ended in Jun. 2008 was $-4.43. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2008 was $-30.43.

NDT Pharmaceuticals's EPS without NRI for the three months ended in Jun. 2008 was $-0.12. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2008 was $-4,284.73.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


NDT Pharmaceuticals EPS (Diluted) Historical Data

The historical data trend for NDT Pharmaceuticals's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NDT Pharmaceuticals EPS (Diluted) Chart

NDT Pharmaceuticals Annual Data
Trend Dec05 Dec06 Dec07
EPS (Diluted)
-0.70 -2.00 -25.00

NDT Pharmaceuticals Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.73 -1.00 -24.00 -1.00 -4.43

Competitive Comparison of NDT Pharmaceuticals's EPS (Diluted)

For the Biotechnology subindustry, NDT Pharmaceuticals's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NDT Pharmaceuticals's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NDT Pharmaceuticals's PE Ratio distribution charts can be found below:

* The bar in red indicates where NDT Pharmaceuticals's PE Ratio falls into.



NDT Pharmaceuticals EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

NDT Pharmaceuticals's Diluted EPS for the fiscal year that ended in Dec. 2007 is calculated as

Diluted EPS (A: Dec. 2007 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.037-0)/0.042
=-24.69

NDT Pharmaceuticals's Diluted EPS for the quarter that ended in Jun. 2008 is calculated as

Diluted EPS (Q: Jun. 2008 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.188-0)/0.042
=-4.48

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-30.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NDT Pharmaceuticals  (OTCPK:NDTP) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


NDT Pharmaceuticals EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of NDT Pharmaceuticals's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


NDT Pharmaceuticals (NDT Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
7325 Oswego Road, Liverpool, NY, USA, 13090
NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury. Its Nanoscale Particle Complex (NPC) technology represents the leading edge of phospholipid-based nano-encapsulation delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth.
Executives
Francisco Kent Carasquero director, officer: Secretary 1057 EAST 21ST AVENUE, CANADA, VANCOUVER BC A1 V5V 1S6

NDT Pharmaceuticals (NDT Pharmaceuticals) Headlines

No Headlines